The "Europe Irritable Bowel Syndrome Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
The researcher announced the results of its Irritable Bowel Syndrome patients study in a new research, Europe Irritable Bowel Syndrome Epidemiology and Patient Flow Analysis - 2018. The research provides insights into Irritable Bowel Syndrome epidemiology, Irritable Bowel Syndrome diagnosed patients, and Irritable Bowel Syndrome treatment rate for EU5 countries. The research measures key indicators including prevalence of Irritable Bowel Syndrome derived from epidemiological analysis, patients diagnosed with Irritable Bowel Syndrome, and patients treated with a drug therapy.
The research study helps executives estimate Irritable Bowel Syndrome market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of Irritable Bowel Syndrome prevalence, Irritable Bowel Syndrome diagnosis rate, and Irritable Bowel Syndrome treatment rate for the period 2017 - 2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.
Key Features of the Report:
For more information about this report visit https://www.researchandmarkets.com/research/jdxk8r/europe_irritable?w=4
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180710005704/en/